201 related articles for article (PubMed ID: 26902226)
1. Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn's Disease.
Gutiérrez A; Zapater P; Juanola O; Sempere L; García M; Laveda R; Martínez A; Scharl M; González-Navajas JM; Such J; Wiest R; Rogler G; Francés R
Am J Gastroenterol; 2016 Apr; 111(4):529-40. PubMed ID: 26902226
[TBL] [Abstract][Full Text] [Related]
2. IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA.
Piñero P; Juanola O; Gutiérrez A; Zapater P; Giménez P; Steinert A; Sempere L; González-Navajas JM; Niess JH; Francés R
J Mol Med (Berl); 2017 Nov; 95(11):1227-1236. PubMed ID: 28879509
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.
Gutiérrez A; Scharl M; Sempere L; Holler E; Zapater P; Almenta I; González-Navajas JM; Such J; Wiest R; Rogler G; Francés R
Gut; 2014 Feb; 63(2):272-80. PubMed ID: 23376290
[TBL] [Abstract][Full Text] [Related]
4. The impact of bacterial DNA translocation on early postoperative outcomes in Crohn's patients undergoing abdominal surgery.
Li Y; Zuo L; Zhu W; Gong J; Zhang W; Gu L; Guo Z; Li N; Li J
J Crohns Colitis; 2015 Mar; 9(3):259-65. PubMed ID: 25555386
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.
Juanola O; Moratalla A; Gutiérrez A; Sempere L; Zapater P; Giménez P; Almenta I; Peiró G; González-Navajas JM; Such JF; Francés R
J Gastroenterol; 2015 Jul; 50(7):758-68. PubMed ID: 25500977
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation.
Lu C; Waugh A; Bailey RJ; Cherry R; Dieleman LA; Gramlich L; Matic K; Millan M; Kroeker KI; Sadowski D; Teshima CW; Todoruk D; Wong C; Wong K; Fedorak RN
World J Gastroenterol; 2012 Sep; 18(36):5058-64. PubMed ID: 23049214
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptide response to blood translocation of bacterial DNA in Crohn's disease is affected by NOD2/CARD15 genotype.
Gutiérrez A; Holler E; Zapater P; Sempere L; Jover R; Pérez-Mateo M; Schoelmerich J; Such J; Wiest R; Francés R
Inflamm Bowel Dis; 2011 Aug; 17(8):1641-50. PubMed ID: 21744420
[TBL] [Abstract][Full Text] [Related]
8. Bacterial DNA translocation contributes to systemic inflammation and to minor changes in the clinical outcome of liver transplantation.
Rodríguez-Laiz GP; Zapater P; Melgar P; Alcázar C; Franco M; Giménez P; Pascual S; Bellot P; Palazón JM; Rodríguez M; Carnicer F; Más-Serrano P; González-Navajas JM; Gómez L; Such J; Lluís F; Francés R;
Sci Rep; 2019 Jan; 9(1):835. PubMed ID: 30696924
[TBL] [Abstract][Full Text] [Related]
9. Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis.
Caro E; Francés R; Zapater P; Pascual S; Bellot P; Such J
Liver Int; 2016 Oct; 36(10):1473-80. PubMed ID: 26991936
[TBL] [Abstract][Full Text] [Related]
10. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the NOD2 gene are associated with a specific phenotype and lower anti-tumor necrosis factor trough levels in Crohn's disease.
Schäffler H; Geiss D; Gittel N; Rohde S; Huth A; Glass Ä; Brandhorst G; Jaster R; Lamprecht G
J Dig Dis; 2018 Nov; 19(11):678-684. PubMed ID: 30284387
[TBL] [Abstract][Full Text] [Related]
12. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
[TBL] [Abstract][Full Text] [Related]
13. Bacterial DNA Translocation Is Associated With Overt Hepatic Encephalopathy and Mortality in Patients With Cirrhosis.
Thanapirom K; Suksawatamnuay S; Wejnaruemarn S; Thaimai P; Siripon N; Ananchuensook P; Sriphoosanaphan S; Vanichanan J; Treeprasertsuk S; Poovorawan Y; Komolmit P
Clin Transl Gastroenterol; 2024 May; 15(5):e00697. PubMed ID: 38488171
[TBL] [Abstract][Full Text] [Related]
14. Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease.
Gutiérrez A; Francés R; Amorós A; Zapater P; Garmendia M; Ndongo M; Caño R; Jover R; Such J; Pérez-Mateo M
Inflamm Bowel Dis; 2009 Apr; 15(4):508-14. PubMed ID: 19058229
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis.
Harputluoglu MM; Dertli R; Otlu B; Demirel U; Yener O; Bilgic Y; Erdogan MA; Atayan Y; Cagin YF
Dig Dis Sci; 2016 Jun; 61(6):1545-52. PubMed ID: 26725065
[TBL] [Abstract][Full Text] [Related]
16. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.
Lakatos PL; Kiss LS; Palatka K; Altorjay I; Antal-Szalmas P; Palyu E; Udvardy M; Molnar T; Farkas K; Veres G; Harsfalvi J; Papp J; Papp M
Inflamm Bowel Dis; 2011 Mar; 17(3):767-77. PubMed ID: 20865702
[TBL] [Abstract][Full Text] [Related]
17. The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation.
Nelson A; Stewart CJ; Kennedy NA; Lodge JK; Tremelling M; ; Probert CS; Parkes M; Mansfield JC; Smith DL; Hold GL; Lees CW; Bridge SH; Lamb CA
J Crohns Colitis; 2021 May; 15(5):800-812. PubMed ID: 33119074
[TBL] [Abstract][Full Text] [Related]
18. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
[TBL] [Abstract][Full Text] [Related]
19. Serum calprotectin as a biomarker for Crohn's disease.
Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
[TBL] [Abstract][Full Text] [Related]
20. Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.
Vazeille E; Buisson A; Bringer MA; Goutte M; Ouchchane L; Hugot JP; de Vallée A; Barnich N; Bommelaer G; Darfeuille-Michaud A
J Crohns Colitis; 2015 May; 9(5):410-20. PubMed ID: 25805890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
